AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Hematology Diagnostics Market, 2014-2018 & 2025 - Increasing Prevalence of Blood Disorders Coupled with Adoption of Automated Testing Processes - ResearchAndMarkets.com

March 19, 2019

DUBLIN--(BUSINESS WIRE)--Mar 19, 2019--The “Hematology Diagnostics Market Size, Share & Trends Analysis Report By Product (Instrument, Consumables), By Test Type (Blood Count, Platelet Function, Hemoglobin, Hematocrit), And Segment Forecasts, 2018 - 2025” report has been added to ResearchAndMarkets.com’s offering.

The global hematology diagnostics market size is expected to reach USD 9.39 billion by 2025

It is anticipated to register a CAGR of 5.85% over the forecast period. Increasing prevalence of blood disorders coupled with adoption of automated testing processes are projected to propel the market growth.

Automation of hematology diagnostics process have led to reduced turnaround time thereby accelerating the overall treatment regimen. Furthermore, automation has also led to reduced administrative errors and overall costs of diagnostic tests. Thus, it is expected to boost growth of the hematology testing market in the forthcoming years.

Dominance of hematology analyzers can be attributed to the presence of fully-automated analyzers which are objective, have high-throughput, and are cost-effective. Furthermore, these hematology analyzers can also detect atypical results and can improve measurable parameters such as red cell distribution width, platelet distribution, Reticulocyte (RET) counts, and nucleated red cells counts.

The advent of Point-Of-Care (PoC) hematology testing devices has led to improved diagnostic and patient outcomes. These devices are user-friendly and are available for use outside the hospital settings. This is anticipated to increase the acceptability and accessibility of hematology testing which, in turn, is anticipated to propel market growth.

Product recall and intense market competition leading to price wars are anticipated to hinder market growth. In 2018, Becton Dickinson (BD) and Company recalled Vacutainer EDTA Blood Collection Tubes owing to chemical interference with certain tests. This recall was classified as Class I recall, the most serious type of recall, by the Food and Drug Administration (FDA), thereby indicating that the use of these devices may cause serious injuries or death. Such product recalls can negatively affect the market growth.

Further key findings from the report suggest:

  • Consumables emerged as the largest segment owing to increasing testing and diagnosis of blood disorders
  • Diagnostic labs segment is projected to expand at a lucrative CAGR over the forecast period owing to high prevalence of blood disorders
  • North America held the dominant market share in 2017 owing to favorable reimbursement scenario and presence of sophisticated technological facilities
  • Asia Pacific is projected to witness swift growth during the forecast period owing to the rising healthcare expenditure coupled with focus on quality healthcare infrastructure
  • Few of the key players in hematology testing market include Beckman Coulter, Inc. Abbott Laboratories; F. Hoffmann-La Roche Ltd.; Siemens Healthineers; Mindray Medical International Limited; and Sysmex Corporation.

Key Topics Covered:

Chapter 1 Research Methodology

1.1 Information procurement

1.2 Information or Data Analysis

1.3 Market Formulation & Validation

Chapter 2 Executive Summary

2.1 Market Snapshot

Chapter 3 Market Variables, Trends & Scope

3.1 Market segmentation & scope

3.1.1 Market Driver Analysis

3.1.1.2 Growing incidence of chronic conditions

3.1.1.3 Technological advancement

3.1.1.4 Increasing awareness of blood disorders

3.1.2 Market Restraint Analysis

3.1.2.1 Product recalls

3.1.2.2 High cost of products

3.2 Penetration & growth prospect mapping

3.3 Hematology Testing market - SWOT Analysis, By Factor (political & legal, economic and technological)

3.4 Industry Analysis - Porter’s

Chapter 4 Product Estimates & Trend Analysis

4.1 Hematology Testing market: Product movement analysis

4.2 Instruments

4.3 Consumables

Chapter 5 Test Type Estimates & Trend Analysis

5.1 Hematology Testing market: Test movement analysis

5.2 Blood count

5.3 Platelet function

5.4 Hemoglobin

5.5 Hematocrit

Chapter 6 End-use Estimates & Trend Analysis

6.1 Hematology Testing market: End-use movement analysis

6.2 Hospitals

6.3 Diagnostic labs

6.4 Others

Chapter 8 Regional Estimates & Trend Analysis

8.1 Hematology Testing market share by region, 2017 & 2025

Chapter 9 Competitive Landscape

9.1 Strategy framework

9.2 Company Profiles

  • Abbott
  • Beckman Coulter
  • Sysmex Corporation
  • Horiba
  • Bio-Rad Laboratories
  • Siemens Healthcare
  • F. Hoffmann-La Roche Ltd
  • Mindray
  • Nihon Kohden
  • EKF Diagnostics

For more information about this report visit https://www.researchandmarkets.com/research/rn3mzj/global_hematology?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20190319005384/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Hematology

KEYWORD:

INDUSTRY KEYWORD: HEALTH OTHER HEALTH

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 03/19/2019 05:24 AM/DISC: 03/19/2019 05:24 AM

http://www.businesswire.com/news/home/20190319005384/en